⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic Leukemia

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Rituximab in Treating Young Patients Who Are Receiving Chemotherapy for B-Cell Non-Hodgkin's Lymphoma or B-Cell Acute Lymphoblastic Leukemia

Official Title: Multicenter Therapy Study for Children With Mature B-NHL or B-ALL With a Rituximab - Window Before Chemotherapy

Study ID: NCT00324779

Interventions

rituximab

Study Description

Brief Summary: RATIONALE: Monoclonal antibodies, such as rituximab, can block cancer growth in different ways. Some find cancer cells and kill them or carry cancer-killing substances to them. Others interfere with the ability of cancer cells to grow and spread. Giving rituximab before chemotherapy may be an effective treatment for B-cell non-Hodgkin's lymphoma or B-cell acute lymphoblastic leukemia. PURPOSE: This phase II trial is studying how well rituximab works in treating young patients who are planning to receive chemotherapy for B-cell non-Hodgkin's lymphoma or B-cell acute lymphoblastic leukemia.

Detailed Description: OBJECTIVES: * Determine the response rate in children and adolescents with B-cell non-Hodgkin's lymphoma (B-NHL) or B-cell acute lymphoblastic leukemia (B-ALL) treated with rituximab monotherapy as upfront window therapy before chemotherapy. * Evaluate the effect of rituximab on different histological subtypes of childhood mature B-NHL or B-ALL in patients treated with this regimen. * Investigate the rituximab response in patients treated with this regimen. * Determine the toxicity profile of rituximab in these patients. * Collect pharmacokinetic and pharmacodynamic data from patients treated with this regimen. OUTLINE: This is a multicenter study. Patients receive rituximab IV on day 1. PROJECTED ACCRUAL: A total of 79 patients will be accrued for this study.

Eligibility

Minimum Age:

Eligible Ages: CHILD, ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Kinderklinik - Universitaetsklinikum Aachen, Aachen, , Germany

Klinikum Augsburg, Augsburg, , Germany

Charite - Campus Charite Mitte, Berlin, , Germany

Helios Klinikum Berlin, Berlin, , Germany

Evangelisches Krankenhauus Bielfeld, Biefeld, , Germany

Klinikum Bremen-Mitte, Bremen, , Germany

Children's Hospital, Cologne, , Germany

Vestische Kinderklinik, Datteln, , Germany

Universitatsklinikum Carl Gustav Carus, Dresden, , Germany

Helios Klinikum Erfurt, Erfurt, , Germany

Universitaets - Kinderklinik, Erlangen, , Germany

Universitaetsklinikum Essen, Essen, , Germany

Klinikum der J.W. Goethe Universitaet, Frankfurt, , Germany

Universitaetskinderklinik - Universitaetsklinikum Freiburg, Freiburg, , Germany

Kinderklinik, Giessen, , Germany

Klinik und Poliklinik Fuer Kinder-und Jugendmedizin - Universitaetsklinikum Greifswald, Greifswald, , Germany

University Medical Center Hamburg - Eppendorf, Hamburg, , Germany

Medizinische Hochschule Hannover, Hannover, , Germany

Universitaets-Kinderklinik Heidelberg, Heidelberg, , Germany

Universitaetsklinikum des Saarlandes, Homburg, , Germany

Universitaets - Kinderklinik, Jena, , Germany

Staedtisches Klinikum Karlsruhe gGmbH, Karlsruhe, , Germany

Kinderkrankenhaus Park Schoenfeld, Kassel, , Germany

University Hospital Schleswig-Holstein - Kiel Campus, Kiel, , Germany

Universitaets - Kinderklinik, Leipzig, , Germany

Universitaets - Kinderklinik - Luebeck, Luebeck, , Germany

Universitatsklinikum der MA, Magdeburg, , Germany

Universitaets - Kinderklinik, Marburg, , Germany

Klinik und Poliklinik fuer Kinder und Jugendmedizin - Universitaetsklinikum Muenster, Muenster, , Germany

Krankenhaus Muenchen Schwabing, Munich, , Germany

Dr. von Haunersches Kinderspital der Universitaet Muenchen, Munich, , Germany

Cnopf'sche Kinderklinik, Nuremberg, , Germany

Klinik St. Hedwig-Kinderklinik, Regensburg, , Germany

Olgahospital, Stuttgart, , Germany

Universitaetsklinikum Tuebingen, Tuebingen, , Germany

Comprehensive Cancer Center Ulm at Universitaetsklinikum Ulm, Ulm, , Germany

Universitaets - Kinderklinik Wuerzburg, Wuerzburg, , Germany

University Children's Hospital, Zurich, , Switzerland

Contact Details

Name: Alfred Reiter, MD

Affiliation: University Hospital Erlangen

Role: STUDY_CHAIR

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: